{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:44:48Z","timestamp":1792896288353,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11886-024-02180-w","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T03:32:15Z","timestamp":1736134335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk and Protective Factors of Poor Clinical Outcomes in Heart Failure with Improved Ejection Fraction Population: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"27","author":[{"given":"Wilbert","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apridya","family":"Nurhafizah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Frederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alya Roosrahima","family":"Khairunnisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capella","family":"Kezia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Irfan","family":"Fathoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Samban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Flindy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"issue":"2","key":"2180_CR1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/ehf2.14303","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu D, Hu K, Schregelmann L, Hammel C, Lengenfelder BD, Ertl G, et al. Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction. ESC Hear Fail. 2023;10(2):1358\u201371. https:\/\/doi.org\/10.1002\/ehf2.14303.","journal-title":"ESC Hear Fail"},{"issue":"4","key":"2180_CR2","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/ehf2.13345","volume":"8","author":"Q Li","year":"2021","unstructured":"Li Q, Qiao Y, Tang J, Guo Y, Liu K, Yang B, et al. Frequency, predictors, and prognosis of heart failure with improved left ventricular ejection fraction: a single-centre retrospective observational cohort study. ESC Hear Fail. 2021;8(4):2755\u201364. https:\/\/doi.org\/10.1002\/ehf2.13345.","journal-title":"ESC Hear Fail"},{"issue":"2","key":"2180_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ehf2.12619","volume":"7","author":"J Gu","year":"2020","unstructured":"Gu J, Yin ZF, Zhang HL, Fan YQ, Zhang JF, Wang CQ. Characteristics and outcomes of transitions among heart failure categories: a prospective observational cohort study. ESC Hear Fail. 2020;7(2):616\u201325. https:\/\/doi.org\/10.1002\/ehf2.12619.","journal-title":"ESC Hear Fail"},{"issue":"2","key":"2180_CR4","doi-asserted-by":"publisher","first-page":"e026891","DOI":"10.1161\/JAHA.122.026891","volume":"12","author":"Y Sun","year":"2023","unstructured":"Sun Y, Chen X, Zhang Y, Yu Y, Zhang X, Si J, et al. Reverse atrial remodeling in heart failure with recovered ejection fraction. J Am Heart Assoc. 2023;12(2):e026891. https:\/\/doi.org\/10.1161\/JAHA.122.026891.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"2180_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/heartjnl-2021-319504","volume":"108","author":"M Merlo","year":"2022","unstructured":"Merlo M, Mas\u00e8 M, Perry A, La Franca E, Deych E, Ajello L, et al. Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction. Heart. 2022;108(9):710\u20136. https:\/\/doi.org\/10.1136\/heartjnl-2021-319504.","journal-title":"Heart"},{"issue":"6","key":"2180_CR6","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1002\/ehf2.13630","volume":"8","author":"X Zhang","year":"2021","unstructured":"Zhang X, Sun Y, Zhang Y, Chen F, Dai M, Si J, et al. Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction. ESC Hear Fail. 2021;8(6):5383\u201391. https:\/\/doi.org\/10.1002\/ehf2.13630.","journal-title":"ESC Hear Fail"},{"issue":"1","key":"2180_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jchf.2021.08.007","volume":"10","author":"S Janwanishstaporn","year":"2022","unstructured":"Janwanishstaporn S, Cho JY, Feng S, Brann A, Seo JS, Narezkina A, et al. Prognostic value of global longitudinal strain in patients with heart failure with improved ejection fraction. JACC Hear Fail. 2022;10(1):27\u201337. https:\/\/doi.org\/10.1016\/j.jchf.2021.08.007.","journal-title":"JACC Hear Fail"},{"issue":"12","key":"2180_CR8","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/ejhf.824","volume":"19","author":"J Lup\u00f3n","year":"2017","unstructured":"Lup\u00f3n J, D\u00edez-L\u00f3pez C, de Antonio M, Domingo M, Zamora E, Moliner P, et al. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Eur J Heart Fail. 2017;19(12):1615\u201323. https:\/\/doi.org\/10.1002\/ejhf.824.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"2180_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.cardfail.2023.06.022","volume":"29","author":"Y HAMMER","year":"2023","unstructured":"HAMMER Y, YOSEF M. Heart failure with recovered ejection fraction in patients with nonischemic cardiomyopathy: characteristics, outcomes, and long-term follow-up. J Card Fail. 2023;29(12):1593\u2013602. https:\/\/doi.org\/10.1016\/j.cardfail.2023.06.022.","journal-title":"J Card Fail"},{"issue":"4","key":"2180_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/2047487317750437","volume":"25","author":"ME J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen ME, Andersson C, Vasan RS, K\u00f8ber L, Abdulla J. Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: a systematic review and meta-analyses. Eur J Prev Cardiol. 2018;25(4):366\u201376. https:\/\/doi.org\/10.1177\/2047487317750437.","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"2180_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/ejhf.2512","volume":"24","author":"P Manca","year":"2022","unstructured":"Manca P, Stolfo D, Merlo M, Gregorio C, Cannat\u00e0 A, Ramani F, et al. Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2022;24(7):1171\u20139. https:\/\/doi.org\/10.1002\/ejhf.2512.","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"2180_CR12","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jacc.2018.07.028","volume":"72","author":"GC Mel\u00e9ndez","year":"2018","unstructured":"Mel\u00e9ndez GC, Jordan JH, D\u2019Agostino RB, Lesnefsky EJ, Hundley WG. Accelerated Left Ventricular Interstitial Collagen Deposition after receiving Doxorubicin in Hypertension. J Am Coll Cardiol. 2018;72(13):1555\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.028.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2180_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ehf2.13082","volume":"8","author":"N Zhang","year":"2021","unstructured":"Zhang N, Cai M, Hua W, Hu Y, Niu H, Cai C, et al. Prognostic effects of longitudinal changes in left ventricular ejection fraction with cardiac resynchronization therapy. ESC Hear Fail. 2021;8(1):368\u201379. https:\/\/doi.org\/10.1002\/ehf2.13082.","journal-title":"ESC Hear Fail"},{"issue":"6","key":"2180_CR14","doi-asserted-by":"publisher","first-page":"e011077","DOI":"10.1161\/JAHA.118.011077","volume":"8","author":"CS Park","year":"2019","unstructured":"Park CS, Park JJ, Mebazaa A, Oh IY, Park HA, Cho HJ, et al. Characteristics, outcomes, and treatment of heart failure with improved ejection fraction. J Am Heart Assoc. 2019;8(6):e011077. https:\/\/doi.org\/10.1161\/JAHA.118.011077.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"2180_CR15","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/ejhf.3001","volume":"25","author":"M Pabon","year":"2023","unstructured":"Pabon M, Claggett BL, Wang X, Miao ZM, Chatur S, Bhatt AS, et al. Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial. Eur J Heart Fail. 2023;25(9):1663\u201370. https:\/\/doi.org\/10.1002\/ejhf.3001.","journal-title":"Eur J Heart Fail"},{"key":"2180_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.091","volume":"204","author":"A Menet","year":"2016","unstructured":"Menet A, Guyomar Y, Ennezat PV, Graux P, Castel AL, Delelis F, et al. Prognostic value of left ventricular reverse remodeling and performance improvement after cardiac resynchronization therapy: a prospective study. Int J Cardiol. 2016;204:6\u201311. https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.091.","journal-title":"Int J Cardiol"},{"issue":"3","key":"2180_CR17","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/ehf2.13285","volume":"8","author":"MG Moon","year":"2021","unstructured":"Moon MG, Hwang IC, Choi W, Cho GY, Yoon YE, Park JB, et al. Reverse remodelling by sacubitril\/valsartan predicts the prognosis in heart failure with reduced ejection fraction. ESC Hear Fail. 2021;8(3):2058\u201369. https:\/\/doi.org\/10.1002\/ehf2.13285.","journal-title":"ESC Hear Fail"},{"issue":"13","key":"2180_CR18","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jacc.2018.06.070","volume":"72","author":"J Merken","year":"2018","unstructured":"Merken J, Brunner-La Rocca HP, Weerts J, Verdonschot J, Hazebroek M, Schummers G, et al. Heart failure with recovered ejection fraction. J Am Coll Cardiol. 2018;72(13):1557\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2018.06.070.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2180_CR19","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/ehf2.14303","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu D, Hu K, Schregelmann L, Hammel C, Lengenfelder BD, Ertl G, et al. Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction. ESC Hear Fail. 2023;10(2):1358\u201371.","journal-title":"ESC Hear Fail"},{"issue":"12","key":"2180_CR20","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/ehf2.14303","volume":"19","author":"J Lup\u00f3n","year":"2017","unstructured":"Lup\u00f3n J, D\u00edez-L\u00f3pez C, de Antonio M, Domingo M, Zamora E, Moliner P, et al. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Eur J Heart Fail. 2017;19(12):1615\u201323. https:\/\/doi.org\/10.1002\/ehf2.14303.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"2180_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/europace\/eut339","volume":"16","author":"M Zecchin","year":"2014","unstructured":"Zecchin M, Proclemer A, Magnani S, Vitali-Serdoz L, Facchin D, Muser D, et al. Long-term outcome of super-responder patients to cardiac resynchronization therapy. Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias. Card Cell Electrophysiol Eur Soc Cardiol. 2014;16(3):363\u201371. https:\/\/doi.org\/10.1093\/europace\/eut339.","journal-title":"Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"12","key":"2180_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.cardfail.2023.06.022","volume":"29","author":"Y Hammer","year":"2023","unstructured":"Hammer Y, Yosef M, Khalatbari S, Aaronson KD. Heart failure with recovered ejection fraction in patients with nonischemic cardiomyopathy: characteristics, outcomes, and long-term follow-up. J Card Fail. 2023;29(12):1593\u2013602. https:\/\/doi.org\/10.1016\/j.cardfail.2023.06.022.","journal-title":"J Card Fail"},{"issue":"7","key":"2180_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jchf.2021.03.010","volume":"9","author":"BP Halliday","year":"2021","unstructured":"Halliday BP, Vazir A, Owen R, Gregson J, Wassall R, Lota AS, et al. Heart Rate as a marker of Relapse during Withdrawal of Therapy in recovered dilated Cardiomyopathy. JACC Heart Fail. 2021;9(7):509\u201317. https:\/\/doi.org\/10.1016\/j.jchf.2021.03.010.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"2180_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.11909\/j.issn.1671-5411.2019.03.015","volume":"16","author":"YR Hu","year":"2019","unstructured":"Hu YR, Hua W, Jin H, Gu M, Fan XH, Niu HX, et al. Does \u2018super-responder\u2019 patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center. J Geriatr Cardiol. 2019;16(3):255\u201362. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2019.03.015.","journal-title":"J Geriatr Cardiol"},{"issue":"10166","key":"2180_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","volume":"393","author":"BP Halliday","year":"2019","unstructured":"Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2019;393(10166):61\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(18)32484-X.","journal-title":"Lancet"},{"issue":"2","key":"2180_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1253\/circj.cj-12-0507","volume":"77","author":"JO Choi","year":"2013","unstructured":"Choi JO, Kim EY, Lee GY, Lee SC, Park SW, Kim DK, et al. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy. Circ J. 2013;77(2):462\u20139. https:\/\/doi.org\/10.1253\/circj.cj-12-0507.","journal-title":"Circ J"},{"issue":"26","key":"2180_CR27","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1093\/eurheartj\/ehz233","volume":"40","author":"A Ghimire","year":"2019","unstructured":"Ghimire A, Fine N, Ezekowitz JA, Howlett J, Youngson E, McAlister FA. Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study. Eur Heart J. 2019;40(26):2110\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehz233.","journal-title":"Eur Heart J"},{"key":"2180_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ahj.2016.06.019","volume":"179","author":"NA Gilotra","year":"2016","unstructured":"Gilotra NA, Bennett MK, Shpigel A, Ahmed HM, Rao S, Dunn JM, et al. Outcomes and predictors of recovery in acute-onset cardiomyopathy: a single-center experience of patients undergoing endomyocardial biopsy for new heart failure. Am Heart J. 2016;179:116\u201326. https:\/\/doi.org\/10.1016\/j.ahj.2016.06.019.","journal-title":"Am Heart J"},{"key":"2180_CR29","doi-asserted-by":"publisher","first-page":"725399","DOI":"10.3389\/fcvm.2021.725399","volume":"8","author":"Y Chen","year":"2021","unstructured":"Chen Y, Qiu Z, Jiang J, Su X, Huang F, Tang J, et al. Outcomes of spironolactone withdrawal in dilated Cardiomyopathy with Improved Ejection Fraction. Front Cardiovasc Med. 2021;8:725399. https:\/\/doi.org\/10.3389\/fcvm.2021.725399.","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"2180_CR30","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1038\/s41591-022-02102-9","volume":"28","author":"O Vardeny","year":"2022","unstructured":"Vardeny O, Fang JC, Desai AS, Jhund PS, Claggett B, Vaduganathan M, et al. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nat Med. 2022;28(12):2504\u201311. https:\/\/doi.org\/10.1038\/s41591-022-02102-9.","journal-title":"Nat Med"},{"issue":"8","key":"2180_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9082426","volume":"9","author":"A Cannata","year":"2020","unstructured":"Cannata A, Manca P, Nuzzi V, Gregorio C, Artico J, Gentile P, et al. Sex-specific prognostic implications in dilated cardiomyopathy after left ventricular reverse remodeling. J Clin Med. 2020;9(8):1\u201311. https:\/\/doi.org\/10.3390\/jcm9082426.","journal-title":"J Clin Med"},{"key":"2180_CR32","doi-asserted-by":"publisher","unstructured":"Zou CH, Zhang J, Prevalence. Predictors and Prognostic Value of Left Ventricular Reverse Remodeling and Relapse in patients hospitalized with dilated cardiomyopathy with long-term echocardiographic follow-up. J Card Fail [Internet]. 2020;26(10):S94. https:\/\/doi.org\/10.1016\/j.cardfail.2020.09.276.","DOI":"10.1016\/j.cardfail.2020.09.276"},{"issue":"1","key":"2180_CR33","doi-asserted-by":"publisher","first-page":"8768","DOI":"10.1038\/s41598-022-12823-z","volume":"12","author":"T Takada","year":"2022","unstructured":"Takada T, Matsuura K, Minami Y, Abe T, Yoshida A, Kishihara M, et al. Prognosis and diastolic dysfunction predictors in patients with heart failure and recovered ejection fraction. Sci Rep. 2022;12(1):8768. https:\/\/doi.org\/10.1038\/s41598-022-12823-z.","journal-title":"Sci Rep"},{"key":"2180_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamacardio.2023.5318","volume":"55417","author":"O Vardeny","year":"2024","unstructured":"Vardeny O, Desai AS, Jhund PS, Fang JC, Claggett B, de Boer RA, et al. Dapagliflozin and Mode of death in heart failure with improved ejection Fraction A Post Hoc Analysis of the DELIVER Trial. JAMA Cardiol. 2024;55417:1\u20136. https:\/\/doi.org\/10.1001\/jamacardio.2023.5318.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"2180_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.122.026891","volume":"12","author":"Y Sun","year":"2023","unstructured":"Sun Y, Chen X, Zhang Y, Yu Y, Zhang X, Si J, et al. Reverse atrial remodeling in heart failure with recovered ejection fraction. J Am Heart Assoc. 2023;12(2):1\u201310. https:\/\/doi.org\/10.1161\/JAHA.122.026891.","journal-title":"J Am Heart Assoc"},{"key":"2180_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijcard.2022.03.046","volume":"357","author":"K Su","year":"2022","unstructured":"Su K, Li M, Wang L, Tian S, Su J, Gu J, et al. Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction. Int J Cardiol. 2022;357:72\u201380. https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.046.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2180_CR37","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1038\/s41598-022-08630-1","volume":"12","author":"M Shiba","year":"2022","unstructured":"Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, et al. Left atrial reverse remodeling improves risk stratification in patients with heart failure with recovered ejection fraction. Sci Rep. 2022;12(1):4473. https:\/\/doi.org\/10.1038\/s41598-022-08630-1.","journal-title":"Sci Rep"},{"key":"2180_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.amjcard.2022.03.006","volume":"173","author":"AS Perry","year":"2022","unstructured":"Perry AS, Mudigonda P, Huang GS, Qureshi B, Cheng RK, Levy WC, et al. Long-term outcomes and risk stratification of patients with heart failure with recovered ejection fraction. Am J Cardiol. 2022;173:80\u20137.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2180_CR39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.amjcard.2022.03.006","volume":"152","author":"S Muzzarelli","year":"2006","unstructured":"Muzzarelli S, Pfisterer M. Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J. 2006;152(5):991\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2022.03.006.","journal-title":"Am Heart J"},{"issue":"7","key":"2180_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jacc.2008.04.044","volume":"52","author":"IS Anand","year":"2008","unstructured":"Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol. 2008;52(7):501\u201311. https:\/\/doi.org\/10.1016\/j.jacc.2008.04.044.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2180_CR41","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1161\/01.CIR.0000095029.57483.60","volume":"108","author":"D Bello","year":"2003","unstructured":"Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108(16):1945\u201353. https:\/\/doi.org\/10.1161\/01.CIR.0000095029.57483.60.","journal-title":"Circulation"},{"issue":"6","key":"2180_CR42","doi-asserted-by":"publisher","first-page":"e003788","DOI":"10.1161\/CIRCHEARTFAILURE.116.003788","volume":"10","author":"L Adamo","year":"2017","unstructured":"Adamo L, Perry A, Novak E, Makan M, Lindman BR, Mann DL. Abnormal global longitudinal strain predicts future deterioration of left ventricular function in heart failure patients with a recovered left ventricular ejection Fraction. Circ Hear Fail. 2017;10(6):e003788. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003788.","journal-title":"Circ Hear Fail"},{"issue":"1","key":"2180_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcmg.2016.11.003","volume":"10","author":"L Thomas","year":"2017","unstructured":"Thomas L, Abhayaratna WP. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging. 2017;10(1):65\u201377. https:\/\/doi.org\/10.1016\/j.jcmg.2016.11.003.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"14","key":"2180_CR44","doi-asserted-by":"publisher","first-page":"e016010","DOI":"10.1161\/JAHA.119.016010","volume":"9","author":"C Madelaire","year":"2020","unstructured":"Madelaire C, Gustafsson F, Stevenson LW, Kristensen SL, K\u00f8ber L, Andersen J, et al. One-year Mortality after Intensification of Outpatient Diuretic Therapy. J Am Heart Assoc. 2020;9(14):e016010. https:\/\/doi.org\/10.1161\/JAHA.119.016010.","journal-title":"J Am Heart Assoc"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02180-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02180-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02180-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:53:53Z","timestamp":1772096033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02180-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02180-w","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"18 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflict of interest concerning the research, authorship, and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Inform Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4"}}